Naji Salem
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 13, 2025
Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?
Journal: Journal of contemporary brachytherapy
Published: October 07, 2025
Chemotherapy-induced anemia as a prognostic factor for overall survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and cystectomy.
Journal: World journal of urology
Published: September 05, 2025
Magnetic resonance imaging-guided radiotherapy for prostate cancer: A systematic review of the literature.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: May 17, 2025
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 29, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Journal: Lancet (London, England)
Published: June 03, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Journal: The Lancet. Oncology
Published: March 14, 2024
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Journal: Clinical and translational radiation oncology
Published: September 10, 2023
A novel lung SBRT treatment planning: Inverse VMAT plan with leaf motion limitation to ensure the irradiation reproducibility of a moving target.
Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists
Published: July 24, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments.
Journal: Brachytherapy
Published: December 26, 2022
Is MRI-Linac helpful in SABR treatments for liver cancer?
Journal: Frontiers in oncology
Published: December 23, 2022
Impact of long-term indwelling JJ stent on renal volume and renal function.
Journal: Minerva urology and nephrology
Published: November 16, 2022
Last Updated: 09/26/2026